Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 2
Clinical trial NCT03332355 · TERMINATED
Trial details
- NCT number
- NCT03332355
- Sponsor
- Vanquish Oncology, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-01
- Primary completion
- 2021-12-31
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.